{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-229280","form_type":"8-K","ticker":"RANI","cik":"0001856725","company_name":"Rani Therapeutics Holdings, Inc.","filed_at":"2022-08-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.478959+00:00","generated_at":"2026-06-23T21:28:27.134394+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Rani Therapeutics enters $150M ATM equity offering agreement with Cantor and H.C. Wainwright","bullets":["Up to $150M of Class A common stock may be sold at market prices on Nasdaq through agents Cantor Fitzgerald and H.C. Wainwright.","Agent compensation set at up to 3.0% of gross sales price per share sold.","Offering under effective shelf registration (Form S-3, effective Aug 10, 2022); prospectus supplement filed Aug 24, 2022.","Rani not obligated to sell any shares; agreement may be terminated by either party with 10 days' notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-229280","json":"https://secwatch.observer/filing/0001193125-22-229280.json","markdown":"https://secwatch.observer/filing/0001193125-22-229280.md","text":"https://secwatch.observer/filing/0001193125-22-229280.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1856725/000119312522229280/0001193125-22-229280-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1856725/000119312522229280/d385381d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T21:28:27.134394+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}